scholarly journals Impact of the coronavirus disease (COVID-19) crisis on older patients with epilepsy

2021 ◽  
Vol 13 (1) ◽  
pp. 17-21
Author(s):  
Takafumi Kubota ◽  
Naoto Kuroda
Drugs & Aging ◽  
2021 ◽  
Author(s):  
Simona Lattanzi ◽  
Claudia Cagnetti ◽  
Nicoletta Foschi ◽  
Roberta Ciuffini ◽  
Elisa Osanni ◽  
...  

2017 ◽  
Vol 79 (02) ◽  
pp. 152-158 ◽  
Author(s):  
Jitka Kocvarova ◽  
Zdenek Novak ◽  
Irena Dolezalova ◽  
Michal Svoboda ◽  
Milan Brazdil ◽  
...  

Introduction We analyzed the results of vagus nerve stimulation (VNS) on older patients and patients with long-lasting epilepsy and included severely intellectually disabled patients. Patients and Methods A total of 103 adults with VNS implanted from 2005 to 2014 were studied. The responder rates, that is, the percentage of VNS patients who responded to VNS, classified as seizure reduction ≥ 50% (50R) and seizure reduction ≥ 90% (90R), were compared in defined age groups (< 40 and ≥ 40 years, and < 50 and ≥ 50 years) and epilepsy duration groups (< 20 and ≥ 20 years, < 30 and ≥ 30 years, and < 40 and ≥ 40 years) at the 1-year follow-up visit and the last follow-up visit (at least 2 years after surgery). The age distributions and responder rates were also studied in patients with an intellectual disability. Results The analysis did not confirm a significantly lower 50R or 90R rate in patients ≥ 40, ≥ 50, or ≥ 60 years when compared with their younger counterparts, but the 50R rate increase during follow-up care was the lowest in patients ≥ 50 and ≥ 60 years. The highest percentage of patients with an intellectual disability in the group < 40 years of age did not adversely affect the 50R rate. Longer epilepsy duration was not confirmed as a negative predictor of VNS outcome. There was a significantly higher 50R rate in patients with epilepsy duration ≥ 20 years (at the last follow-up visit) and a higher 90R rate in patients with epilepsy duration ≥ 30 years (at the 1-year follow-up visit). The increase in the 50R rate during follow-up care was lower in patients with epilepsy durations ≥ 30 and ≥ 40 years. Conclusions The study did not find worse VNS outcomes, as defined by the 50R or 90R rate, in older adult patients or in patients with a longer epilepsy duration. The increasing stimulation effect over time is less marked in older patients and in patients with longer epilepsy duration.


Brain ◽  
2018 ◽  
Vol 141 (6) ◽  
pp. 1592-1608 ◽  
Author(s):  
Arjune Sen ◽  
Valentina Capelli ◽  
Masud Husain

2011 ◽  
Vol 02 (01) ◽  
pp. 033-038 ◽  
Author(s):  
Pushparaja H Shetty ◽  
K Punith ◽  
Ravishankar K Naik ◽  
AO Saroja

ABSTRACT Background: People with epilepsy have impairment in their quality of life (QOL) due to effect of epilepsy on various aspects of their life and the medication effects. Systematic studies on QOL in epilepsy from developing countries are sparse. Objectives: To assess the QOL in people with epilepsy and to evaluate various factors affecting the QOL in them. Materials and Methods: People with generalized and partial epilepsy on medication aged more than 18 years were included in the study. The QOL was assessed with QOLIE-89 instrument. Statistical significance was evaluated by the use of Chi-square test and one-way analysis of variance (ANOVA). Results: Sixty people with epilepsy were studied among whom the older patients had lower overall QOL scores compared to younger patients. Female patients had lower scores compared to males. Married people had lower quality of health score. Patients with simple partial seizures had lowest overall QOL mean score. There was reduction in the overall QOLIE scores with increasing duration of the epilepsy. Patients who had their last seizure within 10 months prior to evaluation had lower mean overall scores. Conclusion: QOL was impaired in people with epilepsy with increased impairment in women, older patients, simple partial seizures, and those with recent seizure.


2012 ◽  
Vol 17 (2) ◽  
pp. 69-75 ◽  
Author(s):  
Pamela A. Smith

In this article, I will review the available recent literature about the aging population with autism, a patient group that researchers know little about and a group that is experiencing a growing need for support from communication disorders professionals. Speech-language pathologists working with geriatric patients should become familiar with this issue, as the numbers of older patients with autism spectrum disorders is likely to increase. Our profession and our health care system must prepare to meet the challenge these patients and residents will present as they age.


2009 ◽  
Vol 40 (8) ◽  
pp. 17
Author(s):  
RENÉE MATTHEWS

2005 ◽  
Vol 38 (11) ◽  
pp. 56
Author(s):  
MITCHEL L. ZOLER
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document